IRIDEX CORP
IRIDEX CORP
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 5 | 5 | 6 | 6 | 7 | 7 | 2 | 4 | 4 | 5 | 7 | 8 | |||||
Accounts Receivable Net Current | 6 | 7 | 8 | 7 | 7 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | |||||
Inventory Net | 10 | 9 | 8 | 7 | 8 | 10 | 11 | 11 | 11 | 11 | 10 | 10 | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | |||||
Assets Current | 24 | 25 | 25 | 24 | 27 | 29 | 24 | 24 | 25 | 28 | 27 | 27 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Finite Lived Intangible Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Assets | 27 | 28 | 29 | 28 | 32 | 34 | 29 | 30 | 31 | 34 | 34 | 35 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 7 | 6 | 5 | 4 | 5 | 6 | 7 | 6 | 8 | 8 | 4 | 3 | |||||
Employee Related Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 1 | |||||
Convertible Notes Payable Current | - | - | 0 | 0 | 0 | 0 | 2 | 1 | - | - | 0 | - | |||||
Other Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Product Warranty Accrual Classified Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Contract With Customer Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 13 | 13 | 13 | 12 | 14 | 15 | 17 | 16 | 16 | 16 | 13 | 10 | |||||
Liabilities Noncurrent | |||||||||||||||||
Contract With Customer Liability Noncurrent | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 10 | 10 | |||||
Product Warranty Accrual Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Convertible Long Term Notes Payable | 4 | 4 | 4 | 4 | 4 | 4 | 1 | 1 | - | - | 0 | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 24 | 24 | 24 | 24 | 26 | 27 | 27 | 28 | 27 | 28 | 25 | 23 | |||||
Preferred Stock Value | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 92 | 92 | 91 | 91 | 91 | 90 | 90 | 90 | 89 | 89 | 88 | 88 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -94 | -93 | -92 | -92 | -91 | -90 | -88 | -87 | -85 | -83 | -79 | -76 | |||||
Stockholders Equity | 4 | 5 | 5 | 5 | 6 | 1 | 2 | 3 | 4 | 6 | 10 | 12 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Liabilities And Stockholders Equity | 27 | 28 | 29 | 28 | 32 | 34 | 29 | 30 | 31 | 34 | 34 | 35 | |||||
Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Series B Convertible Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | - | - | - | - | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 64 | 64 | 64 | 64 | 64 | 30 | 64 | 30 | 30 | 30 | 30 | 30 | |||||
Common Stock Shares Issued | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 16 | |||||
Shares Outstanding | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 16 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.67% | 4.76% | -20.95% | - | - | - | - | - | - | - | - | - |
| 2025 | -11.82% | -15.45% | 16.36% | 7.69% | -7.69% | -19.23% | -1.05% | 23.16% | 56.84% | 8.16% | 3.06% | 15.31% |
| 2024 | -25.32% | -32.79% | -36.69% | 7.49% | -4.28% | -18.72% | 26.95% | 25.53% | 16.31% | 15.91% | 14.77% | 6.82% |
| 2023 | - | - | - | - | - | - | 27.14% | 43.81% | 25.71% | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.82 | 1.92 | 1.91 | 1.94 | 1.96 | 1.95 | 1.42 | 1.54 | 1.55 | 1.72 | 2.12 | 2.64 | |||||
| Quick Ratio | 0.89 | 1.01 | 1.18 | 1.22 | 1.23 | 1.11 | 0.65 | 0.73 | 0.75 | 0.91 | 1.29 | 1.56 | |||||
| Working Capital | 10.79M | 11.76M | 12.04M | 11.67M | 13.16M | 14.18M | 7.00M | 8.49M | 8.86M | 11.51M | 14.48M | 16.99M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 6.49 | 4.98 | 4.92 | 5.06 | 4.21 | 32.14 | 12.89 | 10.50 | 6.36 | 4.25 | 2.62 | 1.90 | |||||
| Debt Ratio | 0.87 | 0.83 | 0.83 | 0.83 | 0.81 | 0.80 | 0.93 | 0.91 | 0.86 | 0.81 | 0.72 | 0.65 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.75 | 1.68 | 1.81 | 1.73 | 1.58 | 1.43 | 1.53 | 1.49 | 1.46 | 1.33 | 1.35 | 1.37 | |||||
| Days Sales Outstanding TTM | 45.33 | 46.94 | 46.99 | 47.15 | 49.18 | 49.38 | 47.54 | 45.46 | 46.58 | 49.19 | 45.59 | 40.99 | |||||
| Receivables Turnover TTM | 8.05 | 7.78 | 7.77 | 7.74 | 7.42 | 7.39 | 7.68 | 8.03 | 7.84 | 7.42 | 8.01 | 8.90 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.20 | -0.19 | -0.26 | -0.30 | -0.32 | -0.43 | -0.54 | -0.67 | -0.67 | -0.67 | -0.59 | -0.48 | |||||
| Free Cash Flow Per Share TTM | -0.11 | -0.15 | -0.13 | -0.23 | -0.35 | -0.41 | -0.44 | -0.43 | -0.36 | -0.35 | -0.43 | -0.47 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 35.92% | 35.97% | 36.50% | 38.18% | 39.49% | 41.18% | 40.07% | 38.82% | 40.44% | 40.72% | 42.04% | 43.19% | |||||
| Operating Profit Margin TTM | -5.39% | -5.12% | -4.88% | -6.04% | -7.07% | -10.68% | -17.06% | -22.47% | -21.53% | -21.95% | -19.29% | -15.27% | |||||
| Net Profit Margin TTM | -6.88% | -6.23% | -8.42% | -10.04% | -10.95% | -14.61% | -18.31% | -22.79% | -21.85% | -21.92% | -18.45% | -14.21% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 3.68% | 7.73% | 8.23% | 4.58% | 0.09% | -2.24% | -6.17% | -11.31% | -11.87% | -12.86% | -8.96% | -4.25% | |||||
| Net Income Growth (1Y) | -34.88% | -54.08% | -50.20% | -53.91% | -49.83% | -34.83% | -6.90% | 42.25% | 39.71% | 51.04% | 26.81% | -12.26% | |||||
| EPS Growth (1Y) | -37.22% | -55.63% | -51.66% | -55.07% | -51.34% | -36.68% | -8.66% | 39.25% | 37.56% | 48.69% | 25.31% | -13.58% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -5.65 | -5.34 | -4.35 | -3.81 | -2.71 | -2.32 | -3.10 | -2.63 | -3.24 | -4.43 | -4.74 | -5.31 | |||||
| P/B TTM | 5.50 | 3.69 | 3.92 | 4.14 | 2.44 | 19.44 | 13.17 | 11.06 | 8.29 | 7.47 | 4.76 | 3.42 | |||||
| P/S TTM | 0.39 | 0.33 | 0.37 | 0.38 | 0.30 | 0.34 | 0.57 | 0.60 | 0.71 | 0.97 | 0.87 | 0.75 | |||||
| Market Cap | 20.03M | 17.48M | 19.30M | 19.39M | 14.78M | 16.56M | 27.62M | 29.02M | 35.18M | 48.43M | 45.32M | 41.23M | |||||
| Enterprise Value | 19.15M | 16.65M | 17.01M | 17.52M | 11.67M | 12.96M | 27.97M | 27.91M | 31.07M | 43.01M | 38.29M | 33.25M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -2.00M | -2.53M | -2.26M | -3.99M | -5.89M | -6.81M | -7.30M | -7.06M | -5.85M | -5.68M | -6.92M | -7.58M | |||||
| Net Debt | -885.00K | -830.00K | -2.29M | -1.87M | -3.10M | -3.60M | 351.00K | -1.10M | -4.11M | -5.42M | -7.03M | -7.98M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
IRIDEX CORP (IRIX) — SEC Financial Statements & Analysis
IRIDEX CORP (IRIX) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. IRIDEX CORP trades on Nasdaq as: IRIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IRIDEX CORP reported a 3.68% year-over-year revenue growth, a Gross Profit Margin of 35.92% (TTM), a Debt-to-Equity ratio of 6.49x, a Price-to-Sales (P/S) ratio of 0.39x (TTM), a Price-to-Book (P/B) ratio of 5.50x (TTM), at a market cap of $20.03M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 3.68%
- Gross Profit Margin TTM
- 35.92%
- Debt To Equity
- 6.49x
- P/S TTM
- 0.39x
- P/B TTM
- 5.50x
- Market Cap
- $20.03M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IRIDEX CORP in?
IRIDEX CORP (IRIX) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What is IRIX's market cap?
IRIDEX CORP (IRIX) has a market capitalization of $20.03M as of 2026-06-30.
What exchange does IRIX trade on?
IRIDEX CORP (IRIX) trades on the Nasdaq.
Where is IRIDEX CORP incorporated?
IRIDEX CORP is incorporated in DE.